RXRX · Recursion Pharmaceuticals, Inc.
$2.96
-0.05 (-1.66%)
At close · Jul 24
Market Cap
$1.57B
Shares
529.91M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 973,833 | $3.69 | $3,593,444 |
| 2026-06-29 | 1,393,711 | $3.52 | $4,905,863 |
| 2026-06-24 | 7,535 | $3.16 | $23,811 |
| 2026-06-23 | 41,994 | $3.18 | $133,541 |
| 2026-06-22 | 763,878 | $3.23 | $2,467,326 |
| 2026-06-17 | 45,693 | $3.18 | $145,304 |
| 2026-06-16 | 42,067 | $3.29 | $138,400 |
| 2026-06-15 | 14,099 | $3.15 | $44,412 |
| 2026-06-12 | 41,526 | $3.15 | $130,807 |
| 2026-06-10 | 16,440 | $3.22 | $52,937 |
| 2026-06-08 | 36,375 | $3.32 | $120,765 |
| 2026-06-05 | 50,924 | $3.80 | $193,511 |
| 2026-06-04 | 2,451 | $3.47 | $8,505 |
| 2026-06-02 | 45,633 | $3.79 | $172,949 |
| 2026-06-01 | 46,870 | $3.59 | $168,263 |
| 2026-05-29 | 30,279 | $3.44 | $104,160 |
| 2026-05-28 | 27,968 | $3.17 | $88,659 |
| 2026-05-27 | 748,146 | $2.97 | $2,221,994 |
| 2026-05-26 | 9,734 | $3.01 | $29,299 |
| 2026-05-22 | 77,717 | $3.11 | $241,700 |
| 2026-05-21 | 38,295 | $2.96 | $113,353 |
| 2026-05-20 | 329,283 | $2.85 | $938,457 |
| 2026-05-19 | 1,461 | $2.89 | $4,222 |
| 2026-05-18 | 46,354 | $2.93 | $135,817 |
| 2026-05-15 | 122,291 | $3.04 | $371,765 |
| 2026-05-13 | 233,607 | $3.15 | $735,862 |
| 2026-05-12 | 45,174 | $3.26 | $147,267 |
| 2026-05-08 | 15,459 | $3.27 | $50,551 |
| 2026-05-07 | 83,578 | $3.43 | $286,673 |
| 2026-05-06 | 1,798 | $3.37 | $6,059 |
| 2026-05-05 | 14,228 | $3.52 | $50,083 |
| 2026-05-04 | 21,454 | $3.39 | $72,729 |
| 2026-05-01 | 6,623 | $3.46 | $22,916 |
| 2026-04-28 | 20,043 | $3.48 | $69,750 |
| 2026-04-27 | 572,992 | $3.51 | $2,011,202 |
Showing 1–35 of 35 settlements
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
60 filings
60 filers
Visit website
Investor relations